BioTherapeutics are forecast to be the fastest growing sector of the pharmaceutical industry, with big pharmaceutical companies estimated to be generating around 60% of revenue through biologic products by 2010. The BioTherapeutics market is determined to be worth more than $56 billion.

Meanwhile, the cost of drug development continues to rise and development time continues to lengthen. With its diverse patient pool, growing market share, increasing quality talents and inexpensive cost, Asia has been chosen by many global pharmas and biotechs as an important strategic location for cost effective drug development.

Asian countries have been drawing increased attention as major players in BioTherapeutics research. China, India, Japan, Korea and Singapore are racing to grab the lead in this promising field – BioTherapeutics! The favorable regulatory climate, increasing research funding and growing talent pool are drawing the top notch scientists from across the world.

BioTherapeutics Asia 2008 will serve as a timely platform bringing together regulators, researchers, pre-clinical and clinical development professionals from biopharmaceutical companies across Asia Pacific and globally to learn and discuss the best strategies and practices to fast-track new generation BioTherapeutics development to market in Asia.

Pharmaceutical and biotechnology industry leaders will find this a must-attend event that  provides them with the opportunity to network on an interactive level, consisting of a stellar line-up of world-class case study presentations, panel discussions and brainstorming of strategies, and full day of workshops. Industry practitioners will also have the opportunity to exchange innovative ideas, technology updates and business execution models and best-in-breed operational strategies that work best for their industry.

To provide total value to organizations, BioTherapeutics 2008 will be held over 2 days, together with other conferences encompassing the entire industry value-chain including BioInvest, BioLicensing, BioManufaturing, BioLogistics and BioInformatics. These conferences will be power-packed with detailed gritting issues on biological therapeutics development and manufacturing, and will capitalize on Asia's favorable regulatory climate to develop next generation therapeutics.  Plus, unlimited networking opportunities!

Expect to meet a delegation of regional and international pharmaceutical and biotechnology industry executives, venture capitalists & technology vendors and legal consultants at BioTherapeutics Asia 2008.